CXCL5 contributes to tumor metastasis and recurrence of intrahepatic cholangiocarcinoma by recruiting infiltrative intratumoral neutrophils

Carcinogenesis

Volumn 35, Issue 3, 2014, Pages 597-605

  Zhou, Shao Lai ^a   Dai, Zhi ^a   Zhou, Zheng Jun ^a   Chen, Qing ^a   Wang, Zheng ^a   Xiao, Yong Sheng ^a   Hu, Zhi Qiang ^a   Huang, Xiao Yong ^a   Yang, Guo Huan ^a   Shi, Ying Hong ^a   Qiu, Shuang Jian ^a   Fan, Jia ^a   Zhou, Jian ^a  

^a FUDAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

EPITHELIAL DERIVED NEUTROPHIL ACTIVATING FACTOR 78; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PHOSPHATIDYLINOSITOL 3 KINASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BILE DUCT CARCINOMA; CANCER CELL CULTURE; CANCER PROGNOSIS; CANCER RECURRENCE; CANCER SURVIVAL; CELL INVASION; CELL MIGRATION; CELL PROLIFERATION; CELL STIMULATION; CONTROLLED STUDY; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; INTRACELLULAR SIGNALING; INTRATUMORAL NEUTROPHILS; MALE; METASTASIS; MOUSE; NEUTROPHIL; NEUTROPHIL CHEMOTAXIS; NONHUMAN; OVERALL SURVIVAL; PRIORITY JOURNAL; TISSUE MICROARRAY; TUMOR GROWTH; TUMOR XENOGRAFT; UPREGULATION;

CHEMOKINE CXCL5; CHOLANGIOCARCINOMA; HUMANS; LIVER NEOPLASMS; LYMPHOCYTES, TUMOR-INFILTRATING; NEOPLASM METASTASIS; NEUTROPHILS; UP-REGULATION;

EID: 84895826238     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgt397     Document Type: Article

References (40)

1. Siegel,R. et al. (2012) Cancer statistics, 2012. CA. Cancer J. Clin., 62, 10-29.
2. Endo,I. et al. (2008) Intrahepatic cholangiocarcinoma: rising frequency, improved survival, and determinants of outcome after resection. Ann. Surg., 248, 84-96.
3. Zhou,X.D. et al. (2009) Intrahepatic cholangiocarcinoma: report of 272 patients compared with 5,829 patients with hepatocellular carcinoma. J. Cancer Res. Clin. Oncol., 135, 1073-1080.
4. Khan,S.A., et al. (2012) Guidelines for the diagnosis and treatment of cholangiocarcinoma: an update. Gut, 61, 1657-1669.
5. Mantovani,A. (2009) Cancer: inflaming metastasis. Nature, 457, 36-37.
6. Mantovani,A. et al. (2008) Cancer-related inflammation. Nature, 454, 436-444.
7. DeNardo,D.G. et al. (2008) Immune cells as mediators of solid tumor metastasis. Cancer Metastasis Rev., 27, 11-18.
8. Gores,G.J. (2003) Cholangiocarcinoma: current concepts and insights. Hepatology, 37, 961-969.
9. Tyson,G.L. et al. (2011) Risk factors for cholangiocarcinoma. Hepatology, 54, 173-184.
10. Palmer,W.C. et al. (2012) Are common factors involved in the pathogenesis of primary liver cancers? A meta-analysis of risk factors for intrahepatic cholangiocarcinoma. J. Hepatol., 57, 69-76.
11. de Martel,C. et al. (2012) Global burden of cancers attributable to infections in 2008: a review and synthetic analysis. Lancet Oncol., 13, 607-615.
12. Lazennec,G. et al. (2010) Chemokines and chemokine receptors: new insights into cancer-related inflammation. Trends Mol. Med., 16, 133-144.
13. Mantovani,A. et al. (2010) The chemokine system in cancer biology and therapy. Cytokine Growth Factor Rev., 21, 27-39.
14. Koch,A.E. et al. (1994) Epithelial neutrophil activating peptide-78: a novel chemotactic cytokine for neutrophils in arthritis. J. Clin. Invest., 94, 1012-1018.
15. Walz,A. et al. (1991) Structure and neutrophil-activating properties of a novel inflammatory peptide (ENA-78) with homology to interleukin 8. J. Exp. Med., 174, 1355-1362.
16. Park,J.Y. et al. (2007) CXCL5 overexpression is associated with late stage gastric cancer. J. Cancer Res. Clin. Oncol., 133, 835-840.
17. Begley,L.A. et al. (2008) CXCL5 promotes prostate cancer progression. Neoplasia, 10, 244-254.
18. Kuo,P.L. et al. (2011) CXCL5/ENA78 increased cell migration and epithelial-to-mesenchymal transition of hormone-independent prostate cancer by early growth response-1/snail signaling pathway. J. Cell. Physiol., 226, 1224-1231.
19. Wong,Y.F. et al. (2007) Identification of molecular markers and signaling pathway in endometrial cancer in Hong Kong Chinese women by genomewide gene expression profiling. Oncogene, 26, 1971-1982.
20. Miyazaki,H. et al. (2006) Down-regulation of CXCL5 inhibits squamous carcinogenesis. Cancer Res., 66, 4279-4284.
21. Li,A. et al. (2011) Overexpression of CXCL5 is associated with poor survival in patients with pancreatic cancer. Am. J. Pathol., 178, 1340-1349.
22. Zhou,S.L. et al. (2012) Overexpression of CXCL5 mediates neutrophil infiltration and indicates poor prognosis for hepatocellular carcinoma. Hepatology, 56, 2242-2254.
23. Onori,P. et al. (2010) Secretin inhibits cholangiocarcinoma growth via dysregulation of the cAMP-dependent signaling mechanisms of secretin receptor. Int. J. Cancer, 127, 43-54.
24. Huang,X.Y. et al. (2010) Overexpression of CD151 as an adverse marker for intrahepatic cholangiocarcinoma patients. Cancer, 116, 5440-5451.
25. Zhou,Z.J. et al. (2013) Overexpression of HnRNP A1 promotes tumor invasion through regulating CD44v6 and indicates poor prognosis for hepatocellular carcinoma. Int. J. Cancer, 132, 1080-1089.
26. Czepielewski,R.S. et al. (2012) Gastrin-releasing peptide receptor (GRPR) mediates chemotaxis in neutrophils. Proc. Natl Acad. Sci. USA, 109, 547-552.
27. Fridlender,Z.G. et al. (2009) Polarization of tumor-associated neutrophil phenotype by TGF-beta: "N1" versus "N2" TAN. Cancer Cell, 16, 183-194.
28. Zhou,S. et al. (2011) Tacrolimus enhances the invasion potential of hepatocellular carcinoma cells and promotes lymphatic metastasis in a rat model of hepatocellular carcinoma: involvement of vascular endothelial growth factor-C. Transplant. Proc., 43, 2747-2754.
29. St Hill,C.A. et al. (2011) Neutrophil interactions with sialyl Lewis X on human nonsmall cell lung carcinoma cells regulate invasive behavior. Cancer, 117, 4493-4505.
30. Gu,F.M. et al. (2012) Intratumoral IL-17+ cells and neutrophils show strong prognostic significance in intrahepatic cholangiocarcinoma. Ann. Surg. Oncol., 19, 2506-2514.
31. Qiu,Y. et al. (2003) Biopsy neutrophilia, neutrophil chemokine and receptor gene expression in severe exacerbations of chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med., 168, 968-975.
32. Okabe,H. et al. (2012) Identification of CXCL5/ENA-78 as a factor involved in the interaction between cholangiocarcinoma cells and cancerassociated fibroblasts. Int. J. Cancer, 131, 2234-2241.
33. Murdoch,C. et al. (2008) The role of myeloid cells in the promotion of tumour angiogenesis. Nat. Rev. Cancer, 8, 618-631.
34. Sasaki,M. et al. (2003) Intrahepatic cholangiocarcinoma in cirrhosis presents granulocyte and granulocyte-macrophage colony-stimulating factor. Hum. Pathol., 34, 1337-1344.
35. Williams,M.R. et al. (2011) Emerging mechanisms of neutrophil recruitment across endothelium. Trends Immunol., 32, 461-469.
36. Heit,B. et al. (2002) An intracellular signaling hierarchy determines direction of migration in opposing chemotactic gradients. J. Cell Biol., 159, 91-102.
37. Pham,C.T. (2006) Neutrophil serine proteases: specific regulators of inflammation. Nat. Rev. Immunol., 6, 541-550.
38. Imai,Y. et al. (2005) Neutrophils enhance invasion activity of human cholangiocellular carcinoma and hepatocellular carcinoma cells: an in vitro study. J. Gastroenterol. Hepatol., 20, 287-293.
39. Brandau,S. et al. (2013) Protumor and antitumor functions of neutrophil granulocytes. Semin. Immunopathol., 35, 163-176.
40. Donskov,F. (2013) Immunomonitoring and prognostic relevance of neutrophils in clinical trials. Semin. Cancer Biol., 23, 200-207.